Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo.
about
VEGF-Trap: a VEGF blocker with potent antitumor effects.Neuroinflammatory responses in diabetic retinopathyMicrovascular complications and diabetic retinopathy: recent advances and future implicationsPathophysiology of diabetic retinopathyTherapeutic interventions against inflammatory and angiogenic mediators in proliferative diabetic retinopathyVitreous mediators in retinal hypoxic diseasesLeukostasis and pigment epithelium-derived factor in rat models of diabetic retinopathyCalcium dobesilate inhibits the alterations in tight junction proteins and leukocyte adhesion to retinal endothelial cells induced by diabetesCalcium dobesilate in the treatment of diabetic retinopathy.The role of angiogenesis in the development of proliferative diabetic retinopathy: impact of intravitreal anti-VEGF treatment.PPARalpha deficiency in inflammatory cells suppresses tumor growth.Remodeling of retinal Fatty acids in an animal model of diabetes: a decrease in long-chain polyunsaturated fatty acids is associated with a decrease in fatty acid elongases Elovl2 and Elovl4.Vascular dysfunction in retinopathy-an emerging role for arginaseFolic acid treatment normalizes NOS-dependence of vascular tone in the metabolic syndrome.Diabetic macular edema: new concepts in patho-physiology and treatment.Danhong Huayu Koufuye Prevents Diabetic Retinopathy in Streptozotocin-Induced Diabetic Rats via Antioxidation and Anti-Inflammation.Inhibition of reactive oxygen species by Lovastatin downregulates vascular endothelial growth factor expression and ameliorates blood-retinal barrier breakdown in db/db mice: role of NADPH oxidase 4.Effect of antioxidant N-acetylcysteine on diabetic retinopathy and expression of VEGF and ICAM-1 from retinal blood vessels of diabetic rats.Müller cell-derived VEGF is essential for diabetes-induced retinal inflammation and vascular leakageVascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives.Anti-inflammatory effect of docosahexaenoic acid on cytokine-induced adhesion molecule expression in human retinal vascular endothelial cellsEffect of intravitreal bevacizumab on vascular endothelial growth factor expression in patients with proliferative diabetic retinopathy.Inhibition of NOX1/4 with GKT137831: a potential novel treatment to attenuate neuroglial cell inflammation in the retina.Effects of asymmetric dimethylarginine on bovine retinal capillary endothelial cell proliferation, reactive oxygen species production, permeability, intercellular adhesion molecule-1, and occludin expression.Delivery of SAR 1118 to the retina via ophthalmic drops and its effectiveness in a rat streptozotocin (STZ) model of diabetic retinopathy (DR)TNFalpha is required for late BRB breakdown in diabetic retinopathy, and its inhibition prevents leukostasis and protects vessels and neurons from apoptosisDifferences in expression of retinal proteins between diabetic and normal rats.Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetesInsulin-like growth factor-I plays a pathogenetic role in diabetic retinopathyComparative transcriptional analysis of human macrophages exposed to animal and human isolates of Mycobacterium avium subspecies paratuberculosis with diverse genotypes.Alpha-mangostin attenuation of hyperglycemia-induced ocular hypoperfusion and blood retinal barrier leakage in the early stage of type 2 diabetes ratsIntravitreal inhibition of complement C5a reduces choroidal neovascularization in mice.Potential new strategies to prevent the development of diabetic retinopathy.Sugar creates a sticky business: round up the usual suspects.Suppression of diabetic retinopathy with angiopoietin-1.Platelets accumulate in the diabetic retinal vasculature following endothelial death and suppress blood-retinal barrier breakdown.The role of growth factors in the pathogenesis of diabetic retinopathy.Endoplasmic reticulum stress and inflammation: mechanisms and implications in diabetic retinopathy.Inhibition of cytokine signaling in human retinal endothelial cells through modification of caveolae/lipid rafts by docosahexaenoic acidProgression of Diabetic Capillary Occlusion: A Model.
P2860
Q24535043-31E39AFB-4D02-47BD-AB01-1E9829BBCFDFQ26798351-6B3FFE71-24CE-4E8F-A6B8-7ED99239A511Q26822476-28215932-0E20-4A3D-8527-AE4DEFEC04E2Q26865897-66702217-3E93-4E41-A5F9-E20FA37E6424Q27021701-732B20C6-B88B-4342-9CEE-750C399C924DQ27028225-E4326888-20B9-41A9-B74E-D21771D73DE0Q28576755-75778973-E2DE-4E6D-ACC0-4D97C55E1342Q28584295-FFFA25AB-48DC-429F-BF33-EA0F9BD589B5Q30858537-FB332FF9-41D3-4B24-9FEC-F29F4796A63CQ31061150-FEEA8B0F-CEB0-4FAA-A764-BF6C0A93B3F3Q33275971-FE97B85E-7058-4290-BD42-A4ADB2507362Q33556542-729515FF-63B6-4184-94EB-F53DEEFCA45FQ33625727-432387CA-02DB-4A0F-BE49-6970CEACC983Q33701506-8C353E2C-3410-4103-B59F-870D6D6A970BQ33713517-AD7EDA34-D4B7-4079-85FD-16BB27207135Q33791268-B2E8B477-F651-4838-8285-AC5D1BD5B103Q33869840-C348DCF9-2945-40C1-897A-7B09324634B8Q34033023-F0DFC7AF-FAB8-4467-A90B-BC21BCAAF993Q34082890-955B1CFA-BADB-4CA2-B5BE-D020E4D57404Q34280300-551E3ACE-43FB-481C-B300-1EEFBC12995DQ34390960-7A9695CE-8F32-440F-9D15-E9C187F0E3E7Q34474545-51283E09-00EA-4BC7-B215-9F1DDF598893Q34487307-3D71C111-868D-4660-9EB4-4E235C3D0AE3Q34550813-70768026-72BA-468D-95B5-3A00B7E32B1AQ34735196-C9834217-E60A-4622-B6C1-7EDD54064B83Q35005977-85AE7640-A5CB-4B1E-B2F7-870450689414Q35055976-01BE7BDD-98B2-46B6-B49D-6DEA3E725B84Q35070770-80425628-A3C0-4F3C-96DD-CF86F31C2519Q35102944-918BB294-C6AC-4DC8-AE75-C8183B0C86A9Q35217578-55DE5901-3C7F-4468-8856-4EF4930E5BF2Q35530622-5556088D-3DC1-439C-AEED-4C9A9ACAEA07Q35633511-8B10F999-8898-48DF-82F6-F1BA6400B46CQ35688213-CA5FF43D-9156-4519-88E6-C72C9647EA66Q35748024-71983F85-6ED3-4E69-BFFD-3E3B8A5307D8Q35748042-9E961A16-794B-4337-9A5B-189E389D5EDCQ35791582-236B4682-A093-4AA0-8AC6-E4AFD48E79E7Q35906962-577FA404-6700-4E43-AC19-E11D59813BADQ35928460-30AB9856-B593-4D2D-BD0B-96E11D2E8AEDQ35989359-85D3D38E-956F-429C-8854-D477AAF5FBD0Q36051940-3A33DAFE-267E-4544-B337-E200932DC2E7
P2860
Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Retinal vascular endothelial g ...... al leukocyte adhesion in vivo.
@ast
Retinal vascular endothelial g ...... al leukocyte adhesion in vivo.
@en
type
label
Retinal vascular endothelial g ...... al leukocyte adhesion in vivo.
@ast
Retinal vascular endothelial g ...... al leukocyte adhesion in vivo.
@en
prefLabel
Retinal vascular endothelial g ...... al leukocyte adhesion in vivo.
@ast
Retinal vascular endothelial g ...... al leukocyte adhesion in vivo.
@en
P2093
P2860
P1476
Retinal vascular endothelial g ...... al leukocyte adhesion in vivo.
@en
P2093
Anthony P Adamis
Antonia M Joussen
Bernd Kirchhof
George D Yancopoulos
John Rudge
Nicholas Mitsiades
Stanley J Wiegand
Vassiliki Poulaki
Wenying Qin
P2860
P304
P356
10.1016/S0002-9440(10)64869-9
P407
P577
2002-02-01T00:00:00Z